Mavorixafor

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Mavorixafor

CAS No. : 558447-26-0

MCE 国际站：Mavorixafor

产品活性：Mavorixafor (AMD-070) 是一种有效的，选择性的，可口服的 CXCR4 拮抗剂，能够拮抗 ¹²⁵I-SDF 与 CXCR4 结合，IC₅₀ 值为 13 nM；Mavorixafor (AMD-070) 能够抑制 HIV-1 (NL4.3 strain) 的复制，在 MT-4 和 PBMCs 细胞中，IC₅₀ 值分别为 1 和 9 nM。

研究领域：GPCR/G Protein  |  Immunology/Inflammation  |  Anti-infection

作用靶点：CXCR  |  HIV

In Vitro: Mavorixafor (AMD-070) is a potent and orally available CXCR4 antagonist, with an IC₅₀ value of 13 nM against CXCR4 ¹²⁵I-SDF binding, and also inhibits the replication of T-tropic HIV-1 (NL4.3 strain) in MT-4 cells and PBMCs with an IC₅₀ of 1 and 9 nM, respectively. Mavorixafor (AMD-070) shows no effect on other chemokine receptors (CCR1, CCR2b, CCR4, CCR5, CXCR1, and CXCR2). Mavorixafor (AMD-070) (6.6 µM) significantly suppresses the anchorage-dependent growth, the migration and matrigel invasion of the B88-SDF-1 cells.

In Vivo: Mavorixafor (AMD-070) (2 mg/kg, p.o.) significantly reduces the number of metastatic lung nodules in mice, and lowers the expression of human Alu DNA in mice, without body weight loss.

相关产品：Chloroquine  |  Doxorubicin hydrochloride  |  5-Fluorouracil  |  Q-VD-OPh  |  Valproic acid  |  Panobinostat  |  Shikonin  |  Hydroxyurea  |  Probenecid  |  Kaempferol  |  Plerixafor  |  Dimethyl fumarate  |  Birinapant  |  Maraviroc  |  SB225002  |  Baicalin  |  Flavopiridol  |  Ritonavir  |  Ivermectin  |  Fasudil Hydrochloride  |  AMG 487  |  Ebselen  |  Rolipram  |  Betulinic acid  |  Kynurenic acid  |  Reparixin  |  CK-666  |  Oleanolic Acid

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds